Cargando…
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)
BACKGROUND: It remains unclear if intensive antiplatelet and statin treatments begun within 24–72 hours of cerebral ischaemic events from intracranial or extracranial atherosclerosis is effective or safe. METHODS: The Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracrani...
Autores principales: | Gao, Ying, Pan, Yuesong, Han, Shangrong, Chen, Weiqi, Jing, Jing, Wang, Chunjuan, Yang, Yingying, Wang, Tingting, Meng, Xia, Zhao, Xingquan, Liu, Liping, Li, Hao, Johnston, S Claiborne, Amarenco, Pierre, Bath, Philip M, Wang, Yongjun, Wang, Yilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359782/ https://www.ncbi.nlm.nih.gov/pubmed/36707080 http://dx.doi.org/10.1136/svn-2022-002084 |
Ejemplares similares
-
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019) -
Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
por: Suo, Yue, et al.
Publicado: (2020) -
Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
por: Yang, Yingying, et al.
Publicado: (2018) -
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
por: Pan, Yuesong, et al.
Publicado: (2022) -
Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II
por: Yang, Ming, et al.
Publicado: (2019)